Maxim Group analyst Michael Okunewitch maintained a Buy rating on Mind Medicine (MNMD – Research Report) yesterday and set a price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback